RU98109810A - METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS - Google Patents

METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS

Info

Publication number
RU98109810A
RU98109810A RU98109810/14A RU98109810A RU98109810A RU 98109810 A RU98109810 A RU 98109810A RU 98109810/14 A RU98109810/14 A RU 98109810/14A RU 98109810 A RU98109810 A RU 98109810A RU 98109810 A RU98109810 A RU 98109810A
Authority
RU
Russia
Prior art keywords
atherosclerosis
prevention
treatment
dose
carnitine
Prior art date
Application number
RU98109810/14A
Other languages
Russian (ru)
Other versions
RU2148399C1 (en
Inventor
Н.П. Лебкова
Л.М. Алексеева
Т.М. Фролова
Original Assignee
Российская медицинская академия последипломного образования МЗ РФ
Filing date
Publication date
Application filed by Российская медицинская академия последипломного образования МЗ РФ filed Critical Российская медицинская академия последипломного образования МЗ РФ
Priority to RU98109810A priority Critical patent/RU2148399C1/en
Priority claimed from RU98109810A external-priority patent/RU2148399C1/en
Publication of RU98109810A publication Critical patent/RU98109810A/en
Application granted granted Critical
Publication of RU2148399C1 publication Critical patent/RU2148399C1/en

Links

Claims (1)

Способ профилактики и лечения атеросклероза, включающий введение в организм больного лекарственных веществ, отличающийся тем, что последовательно вводят карнитин перорально в дозе 100 мг/кг и уридин внутримышечно в дозе 50 мг/кг один раз в сутки в течение 6-8 дней на курс лечения.A method for the prevention and treatment of atherosclerosis, including the introduction of drugs into the patient’s body, characterized in that carnitine is administered orally at a dose of 100 mg / kg and uridine intramuscularly at a dose of 50 mg / kg once a day for 6-8 days per treatment course .
RU98109810A 1998-05-21 1998-05-21 Method for preventing and treating atherosclerosis RU2148399C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU98109810A RU2148399C1 (en) 1998-05-21 1998-05-21 Method for preventing and treating atherosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU98109810A RU2148399C1 (en) 1998-05-21 1998-05-21 Method for preventing and treating atherosclerosis

Publications (2)

Publication Number Publication Date
RU98109810A true RU98109810A (en) 2000-02-10
RU2148399C1 RU2148399C1 (en) 2000-05-10

Family

ID=20206355

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98109810A RU2148399C1 (en) 1998-05-21 1998-05-21 Method for preventing and treating atherosclerosis

Country Status (1)

Country Link
RU (1) RU2148399C1 (en)

Similar Documents

Publication Publication Date Title
BG106251A (en) Levodopa (carbidopa) entacapone pharmaceutical preparation
CA2307018A1 (en) Osmotic medicament releasing system
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
RU2003119460A (en) APPLICATION OF PEG-INTERFERON-A (PEG-INF-A) AND RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS C
BG104476A (en) Therapeutical form for tolterodin with controlled release
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
IL128416A0 (en) Pharmaceutical composition for the treatment of alzheimer's disease
ES2173111T3 (en) USE OF FENSERINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF COGNOSCITIVE DISORDERS.
CA2150184A1 (en) Pharmaceutical composition for the treatment of inflammatory bowel diseases
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
EP0375628A3 (en) Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment
HK1018211A1 (en) Pharmaceutical combination preparation of an inhibitor of the sodium/dydrogen exchanger and a medicament for the treatment of cardiovascular diseases.
CA2150183A1 (en) Pharmaceutical composition for the treatment of hemorrhoidal diseases
EP0744176A3 (en) Methods for inhibiting bone loss
RU98109810A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
CA2228266A1 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
RU97110383A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
RU95120783A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
DE58909272D1 (en) Orally administrable pharmaceutical agent, in particular for iron and magnesium substitution therapy.
RU2000103385A (en) METHOD FOR TREATING ACUTE PANCREOTITIS
RU97110400A (en) METHOD FOR PREVENTION AND TREATMENT OF PATIENTS SUFFERING WITH ESTROGEN- AND ANDROGEN-DEPENDENT TUMORS
RU96107031A (en) METHOD FOR TREATMENT OF GENTINGTON CHOREA
EA200200559A1 (en) METHOD OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE CONDITIONS
RU97117735A (en) METHOD FOR TREATING DIPHTERIA
RU98103823A (en) METHOD FOR CHANGING A COLLABORATING AND ANTI-COLLISING SYSTEM OF THE ORGANISM